VETMEDIN 1.25 MG CHEWABLE TABLETS FOR DOGS

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Buy It Now

Active ingredient:

PIMOBENDAN

Available from:

Boehringer Ingelheim Animal Health Australia Pty. Ltd.

INN (International Name):

pimobendan(1.25mg/Tb)

Pharmaceutical form:

ORAL BOLUS, CHEWABLE

Composition:

PIMOBENDAN PYRIDAZINONE Active 1.25 mg/Tb

Units in package:

50 tablets

Class:

VM - Veterinary Medicine

Therapeutic group:

DOG | BITCH | CASTRATE | PUPPY

Therapeutic area:

CARDIOVASCULAR SYSTEM

Therapeutic indications:

CONGESTIVE HEART FAILURE | DILATED CARDIOMYOPATHY | MITRAL AND/OR TRICUSPID REGUR | VALVULAR INSUFFICIENCY

Product summary:

Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG: [CONGESTIVE HEART FAILURE, PRECLINICAL DCM, PRECLINICAL MYXOMATOUS MITRAL VALVE DISEASE]; For the treatment of canine congestive heart failure (CHF) originating from dilated cardiomyopathy (DCM) or valvular insufficiency (mitral and/or tricuspid regurgitation).This product is contraindicated for use in cases of hypertrophic cardiomyopathies or clinical conditions where an augmentation of cardiac output is NOT recommended for functional or anatomical reasons.

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

                                 
1
/
Z
N
U
A
/
6
7
9
0
0
0
5
T
 
D
C
B
A
 
D
C
B
A
N
I
D
E
M
T
E
V
®
 
G
M
 
5
2
.
1
 
 
S
G
O
D
 
R
O
F
 
S
T
E
L
B
A
T
 
E
L
B
A
W
E
H
C
 :
T
N
E
U
T
I
T
S
N
O
C
 
E
V
I
T
C
A
 
S
N
I
A
T
N
O
C
 T
E
L
B
A
T
 
H
C
A
E
 
N
A
D
N
E
B
O
M
I
P
 
G
M
 
5
2
.
1
 
S
T
E
L
B
A
T
 
0
5
 
Y
D
E
M
E
R
 
L
A
M
I
N
A
 
N
O
I
T
P
I
R
C
S
E
R
P
 
N
E
R
D
L
I
H
C
 
F
O
 
H
C
A
E
R
 
F
O
 
T
U
O
 
P
E
E
K
 
Y
L
N
O
 
T
N
E
M
T
A
E
R
T
 
L
A
M
I
N
A
 
R
O
F
N
I
D
E
M
T
E
V
®
 
G
M
 
5
2
.
1
 
 
S
G
O
D
 
R
O
F
 
S
T
E
L
B
A
T
 
E
L
B
A
W
E
H
C
 :
T
N
E
U
T
I
T
S
N
O
C
 
E
V
I
T
C
A
 
S
N
I
A
T
N
O
C
 T
E
L
B
A
T
 
H
C
A
E
 
N
A
D
N
E
B
O
M
I
P
 
G
M
 
5
2
.
1
 
S
T
E
L
B
A
T
 
0
5
 t
r
a
e
h
 
e
v
i
t
s
e
g
n
o
c
 
e
n
i
n
a
c
 f
o
 t
n
e
m
t
a
e
r
t
 
e
h
t
 r
o
F
r
o
 
y
h
t
a
p
o
y
m
o
i
d
r
a
c
 
d
e
t
a
li
d
 
m
o
r
f
 
g
n
i
t
a
n
i
g
i
r
o
 
e
r
u
li
a
f
 
d
i
p
s
u
c
i
r
t
 r
o
/
d
n
a
 l
a
r
t
i
m
( 
y
c
n
e
i
c
fi
f
u
s
n
i 
r
a
l
u
v
l
a
v
 
 .
)
n
o
i
t
a
t
i
g
r
u
g
e
r
S
I
H
T
 
G
N
I
S
U
 
E
R
O
F
E
B
 
T
E
L
F
A
E
L
 
D
E
S
O
L
C
N
E
 
E
H
T
 
D
A
E
R
 
 
T
C
U
D
O
R
P
 
E
S
U
 
R
O
F
 
N
O
I
T
C
E
R
I
D
C
I
H
P
O
R
T
R
E
P
Y
H
 
F
O
 
S
E
S
A
C
 
N
I 
D
E
S
U
 
E
B
 T
O
N
 
D
L
U
O
H
S
 
N
A
 
E
R
E
H
W
 
S
N
O
I
T
I
D
N
O
C
 L
A
C
I
N
IL
C
 R
O
 
S
E
I
H
T
A
P
O
Y
M
O
I
D
R
A
C
 
D
E
D
N
E
M
M
O
C
E
R 
T
O
N
 
S
I 
T
U
P
T
U
O
 
C
A
I
D
R
A
C
 
F
O
 
N
O
I
T
A
T
N
E
M
G
U
A
 
 .
S
N
O
S
A
E
R
 L
A
C
I
M
O
T
A
N
A
 R
O
 L
A
N
O
I
T
C
N
U
F
 R
O
F
 
N
O
I
T
A
R
T
S
I
N
I
M
D
A
 
D
N
A
 
E
G
A
S
O
D
o
t
 
g
m
 
2
.
0
 f
o
 
e
g
n
a
r
 
e
s
o
d
 
a
 t
a
 
n
o
i
t
a
r
t
s
i
n
i
m
d
a
 l
a
r
o
 
y
li
a
D
 
e
l
b
a
r
e
f
e
r
p
 
e
h
T
 .
t
h
g
i
e
w
y
d
o
b
 
g
k
/
n
a
d
n
e
b
o
m
i
p
 
g
m
 
6
.
0
 
d
l
u
o
h
s
 
e
s
o
d
 
e
h
T
 .
t
h
g
i
e
w
y
d
o
b
 
g
k
/
g
m
 
5
.
0
 
s
i 
e
s
o
d
 
y
li
a
d
 
y
l
e
t
a
m
i
x
o
r
p
p
a
 t
a
 
s
n
o
i
t
a
r
t
s
i
n
i
m
d
a
 
o
w
t
 
o
t
n
i
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                CS: 1.9.46
Page:
1
MATERIAL SAFETY DATA SHEET
4
of
Infosafe No™
LQ1I5
September 2012
ISSUED by BOEHRING
Issue Date :
VETMEDIN® CHEWABLE TABLETS FOR DOGS
Product Name :
Not classified as hazardous
1. IDENTIFICATION OF THE MATERIAL AND SUPPLIER
VETMEDIN® CHEWABLE TABLETS FOR DOGS
PRODUCT NAME
Boehringer Ingelheim Pty. Limited
COMPANY NAME
78 Waterloo Rd North Ryde
NSW 2113 Australia
ADDRESS
1800 038 037
EMERGENCY TEL.
Tel: 1800 038 037
Fax: +61 2 8875 8715
TELEPHONE/FAX
NUMBER
animalhealth.au@boehringer-ingelheim.com
EMAIL
Vetmedin® chewable tablets are indicated for the treatment of canine
congestive heart failure originating from dilated cardiomyopathy or
valvular
insufficiency (mitral and/or tricuspid regurgitation).
RECOMMENDED USE
2. HAZARDS IDENTIFICATION
Not classified as hazardous
NON-HAZARDOUS SUBSTANCE.
NON-DANGEROUS GOODS.
Not Classified as Hazardous according to criteria of National
Occupational
Health & Safety Commission, Australia (NOHSC).
Not Classified as Dangerous Goods according to the Australian Code for
the
Transport of Dangerous Goods by Road and Rail. (7th edition)
HAZARD
CLASSIFICATION
3. COMPOSITION/INFORMATION ON INGREDIENTS
Pimobendan, a benzimidazole-pyridazinone derivative, is a
non-sympathomimentic, non-glycoside
inotropic substance with potent vasodilatative properties.
1.25 mg beef flavoured palatable chewable tablet contains 1.25 mg
pimobendan
5 mg beef flavoured palatable chewable tablet contains 5 mg pimobendan
2.5 mg beef flavoured palatable chewable tablet contains 2.5 mg
pimobendan
INFORMATION ON
COMPOSITION
NAME
RISK PHRASE
CAS
PROPORTION
HAZARD SYMBOL
INGREDIENTS
Pimobendan
(3(2H)-Pyridazinone,
4,5-dihydro-6-[2-
(4-methoxyphenyl)-1H-be
nzimidazol-5-yl]-5-meth
yl-)
74150-27-9
<=2 %
Ingredients determined
not to be hazardous
-
Balance
4. FIRST AID MEASURES
No special precautions required. However, if inhaled, remove affected
person
from contaminated area. Keep at rest until recovered. If symptoms
persist seek
medical attention.
INHALATION
Do not induce vomiting. Wash out mo
                                
                                Read the complete document